Clonidine is an imidazole derivate that acts as an agonist of alpha-2 adrenoceptors. This activity is useful for the treatment of hypertension, severe pain, and ADHD.
Clonidine was granted FDA approval on 3 September 1974.
Clonidine tablets and transdermal systems are indicated for the treatment of hypertension alone or in combination with other medications. A clonidine injection is indicated for use with opiates in the treatment of severe cancer pain where opiates alone are insufficient. An extended release tablet of clonidine is indicated for the treatment of ADHD either alo...
Memorial Hermann Hospital, Houston, Texas, United States
University of Texas MD Anderson Cancer Center, Houston, Texas, United States
University Medical Centre, Ljubljana, Slovenia
Institut Jules Bordet, Bruxelles, Belgium
Hennepin County Medical Center, Minneapolis, Minnesota, United States
Mayo Clinic Rochester, Rochester, Minnesota, United States
Virginia Commonwealth University, Richmond, Virginia, United States
Universiy hospital, Limoges, France
University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.